scispace - formally typeset
Journal ArticleDOI

Basilar artery occlusion

Reads0
Chats0
TLDR
If BAO is recognised early and confirmed with multimodal CT or MRI, intravenous thrombolysis or endovascular treatment can be undertaken, however, the best treatment approach to improve clinical outcome still needs to be ascertained.
Abstract
The clinical presentation of basilar artery occlusion (BAO) ranges from mild transient symptoms to devastating strokes with high fatality and morbidity. Often, non-specific prodromal symptoms such as vertigo or headaches are indicative of BAO, and are followed by the hallmarks of BAO, including decreased consciousness, quadriparesis, pupillary and oculomotor abnormalities, dysarthria, and dysphagia. When clinical findings suggest an acute brainstem disorder, BAO has to be confirmed or ruled out as a matter of urgency. If BAO is recognised early and confirmed with multimodal CT or MRI, intravenous thrombolysis or endovascular treatment can be undertaken. The goal of thrombolysis is to restore blood flow in the occluded artery and salvage brain tissue; however, the best treatment approach to improve clinical outcome still needs to be ascertained.

read more

Citations
More filters
Journal ArticleDOI

Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.

Xinfeng Liu, +87 more
- 01 Feb 2020 - 
TL;DR: There was no evidence of a difference in favourable outcomes of patients receiving endovascular therapy compared with those receiving standard medical therapy alone, and the trial was terminated early after 131 patients had been randomly assigned because of high crossover rate and poor recruitment.
Journal ArticleDOI

Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry

TL;DR: Among patients with acute BAO, EVT administered within 24 hours of estimated occlusion time is associated with better functional outcomes and reduced mortality, and this nonrandomized cohort study was a nationwide prospective registry of consecutive patients presenting with an acute, symptomatic, radiologically confirmed BAO to 47 comprehensive stroke centers in China.
Journal ArticleDOI

Randomized controlled trials - a matter of design

TL;DR: This review summarizes commonly applied designs and quality indicators of RCTs to provide guidance in interpreting and critically evaluating clinical research data and reflects on the principle of equipoise.
References
More filters
Journal ArticleDOI

Detection of Reversed Basilar Flow With Power-Motion Doppler After Acute Occlusion Predicts Favorable Outcome

TL;DR: In this paper, power-motion transcranial Doppler (PMD-TCD) was used to demonstrate reversed basilar flow in patients with basilar artery (BA) occlusion.
Journal ArticleDOI

First Experiences with a New Device for Mechanical Thrombectomy in Acute Basilar Artery Occlusion

TL;DR: A bridging therapy with the combination of IV thrombolysis with recombinant tissue plasminogen activator and continuous aspiration thrombectomy seems to be a promising therapy strategy for acute basilar artery occlusion.
Journal ArticleDOI

Glasgow coma scale does not predict outcome post-intra-arterial treatment for basilar artery thrombosis

TL;DR: Low GCS score did not correlate with poor neurologic outcome in patients with acute basilar artery thrombosis managed with IA therapy, and it is not appropriate to exclude patients from IA therapy on the basis of low GCS.
Journal ArticleDOI

Intravenous Tissue Plasminogen Activator for the Treatment of Acute Thromboembolic Ischemia

TL;DR: Eighteen patients were treated with 70 mg tissue plasminogen activator intravenously after the onset of acute severe cerebral ischemia: 10 suffered from vertebrobasilar occlusive disease and 8 received treatment with t-PA.
Journal ArticleDOI

Combined Treatment with Intravenous Abciximab and Intraarterial tPA Yields High Recanalization Rate in Patients with Acute Basilar Artery Occlusion

TL;DR: The results of a combined treatment approach with intravenous abciximab and intraarterial tissue plasminogen activator in patients with acute basilar artery occlusion are reported.
Related Papers (5)